Trademark Overview
On Monday, March 4, 2024, a trademark application was filed for TETRAVECTA with the United States Patent and Trademark Office. The USPTO has given the TETRAVECTA trademark a serial number of 98432248. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, January 21, 2025. This trademark is owned by Oxford BioMedica Plc. The TETRAVECTA trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:
Custom manufacture of products relating to biotechnology, namely, custom manufacture of cell and gene therapies; custom manufacture of gene and cell-based therapy products, namely, cell and gene therapies, genetically engineered viral vectors, genetically engineered retroviral vectors, genetically engineered lentiviral vectors, genetically engineered adeno-associated viral vectors, genetically engineered adenoviral vectors, and non-vector preparations in the nature of cell and gene therapies, and biopharmaceutical preparations; biotechnology contract manufacturing services, namely, contract manufacturing in the field of cell and gene therapy using biological organisms; contract manufacturing services of gene and cell-based therapy products, namely, cell and gene therapies, genetically engineered viral vectors, genetically engineered retroviral vectors, genetically engineered lentiviral vectors, genetically engineered adeno-associated viral vectors, genetically engineered adenoviral vec...
Research and laboratory analytic and diagnostic services, namely, scientific research, biochemical research, research laboratory analysis services in the field of gene therapy and biochemistry; product development consultancy in the field of nanotechnology, gene therapy and vector-based delivery systems; product, viral vector product and analytic assay product development for others; laboratory services, namely, scientific laboratory services and biological research laboratory services; research and development services, namely, gene therapy research; genetic engineering laboratories, namely, scientific research in the field of genetic engineering provided in genetic engineering laboratories and biochemistry laboratories providing research and development in the field of biochemistry; scientific and technological services and research, namely, scientific research, analysis, testing in the fields of gene therapy and biochemistry; industrial analysis services, namely, providing analysis ...
